Roswell Park Cancer Institute (RPCI) scientists report a novel enzyme inhibitor, Pevonedistat, demonstrated effectiveness in the laboratory against Mantle Cell Lymphoma (MCL), a rare and aggressive subtype of non-Hodgkin Lymphoma.

Twenty-nine physicians from Roswell Park Cancer Institute (RPCI) are included in the Castle Connolly Medical, Ltd. prestigious America’s Top Doctors® list.

Physicians now have clearer basis for recommending surgical excision for patients in whom magnetic resonance imaging (MRI) detected lobular neoplasia, a known risk factor for developing breast cancer, according to findings reported in Modern Pathology, by researchers at Roswell Park Cancer Institute (RPCI).

The risk of infertility and early menopause increases significantly for women who use tobacco or are exposed to secondhand smoke, according to a study led by Roswell Park researchers and published in the current issue of Tobacco Control.

More than a dozen Roswell Park Cancer Institute (RPCI) researchers were invited to present findings at the American Society of Hematology (ASH) 57th Annual Meeting & Exposition, a four-day meeting in Orlando, Fla., that concluded yesterday.